RESMED INCRMD

Market cap
$35B
P/E ratio
Jun 30,
2012
Jun 30,
2013
Jun 30,
2014
Jun 30,
2015
Jun 30,
2016
Jun 30,
2017
Jun 30,
2018
Jun 30,
2019
Jun 30,
2020
Jun 30,
2021
Jun 30,
2022
Jun 30,
2023
Sleep And Respiratory--------2,6022,8233,1773,725
Software as a Service-----------498
Net revenue1,3691,5141,5551,6791,8392,0672,3402,6072,9573,1973,5784,223
Sleep And Respiratory--------1,0681,1771,3651,663
Software as a Service-----------174
Cost of sales (exclusive of amortization shown separately below)--------1,1901,3131,5141,837
Sleep And Respiratory--------9545
Software as a Service-----------25
Amortization of Intangible Assets14-------50454030
Total cost of sales-------1,0701,2391,3581,5541,867
Gross profit8219419901,0111,0661,2021,3621,5371,7181,8392,0242,356
Selling, general, and administrative402431450479488554600645677670739874
Research and development110120118115119144155181202225254288
Amortization of acquired intangible assets-----------42
Restructuring expenses (note 18)-----------9
Acquisition related expenses-----10-6---11
Total operating expenses5265865856026387768209579089351,0241,224
Income from operations2943554054094294265425798109041,0001,132
Interest (expense) income, net-----------22-47
Income (Loss) from Equity Method Investments--------16-25-11-8-7
Equity Securities, FV-NI, Gain (Loss)-----------1210
Gain on insurance recoveries-----------20
Other, net8-21654-9-11-12153-6
Total other income (loss), net3830262711-7-21-60-77-20-40-30
Income before income taxes3323854314364404195215197338849601,102
Income taxes (note 12)777886838776206114111409181204
Net income255307345353352342316405622475779898
Earnings Per Share, Basic1.752.152.442.512.512.422.212.834.313.275.346.12
Earnings Per Share, Diluted1.712.12.392.472.492.42.192.84.273.245.36.09
Common Stock, Dividends, Per Share, Declared-0.6811.121.21.321.41.481.561.561.681.76